Promoting Change in Practice for Respiratory Failure
NCT07519941 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2026-05-11
Summary
Approximately 300,000 Hispanic individuals experience respiratory failure each year in the U.S. Hispanic patients are twice as likely to die from respiratory failure as non-Hispanic patients. There is an urgent need to identify and remediate mechanisms that increase risk of death from respiratory failure. The team's preliminary work identified two potential mechanisms: Hispanic patients with respiratory failure are more likely to be deeply sedated and less likely to receive physical therapy than non-Hispanic patients, which are both associated with mortality and poor long-term functional outcomes. The overall objective of this proposal is to improve outcomes for patients with respiratory failure through changes in intensive care unit (ICU) practice. This trial will refine and pilot an intervention to promote guideline-concordant care. The team's preliminary intervention will be iteratively refined through patient, family, and clinician engagement and piloted at two U.S. ICUs. The outcome of this study will be an intervention aimed at reducing mortality from respiratory failure.
Conditions
- Acute Respiratory Distress Syndrome (ARDS)
Interventions
- OTHER
-
Safer sedation bundle
This is a unit-level quality improvement intervention to facilitate evidence-based sedation delivery. The quality improvement intervention consists of identification of a safe sedation champion among clinical staff, initiation of sedation rounds, and tools to facilitate structured assessment of sedation depth, delirium, and pain.
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
New York University
lead OTHER
Principal Investigators
-
Mari Armstrong-Hough, PhD, MPH · New York University School of Global Public Health
-
Thomas Valley, MD, MSc · University of Colorado Anschutz School of Medicine
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-08-01
- Primary Completion
- 2027-04-01
- Completion
- 2027-04-01
More Related Trials
-
Efficacy and Safety Evaluation of BZ371B in ARDS Patients
NCT05384379 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
A Phase 2 Study of IC14 in Acute Respiratory Distress Syndrome
NCT03017547 ·Status: WITHDRAWN ·Phase: PHASE2
-
Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants
NCT00807235 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy Study of Nitric Oxide in Patients Going Through Lung Transplantation
NCT00570245 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Nebulized Sodium Nitroprusside in Adult Acute Lung Injury
NCT01619280 ·Status: UNKNOWN ·Phase: PHASE1
-
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
NCT00879606 ·Status: COMPLETED ·Phase: PHASE2
-
Early Insulin and Development of ARDS
NCT00605696 ·Status: COMPLETED ·Phase: PHASE2
-
Cervical Erector Spinae Plane Block for Dyspnea in Acute Respiratory Failure: A Prospective Cohort
NCT07182695 ·Status: NOT_YET_RECRUITING
-
Evaluation of the Feasibility, Safety, and Efficacy of Single-use Endobronchial Silicon Spigots for the Treatment of Refractory Pneumothorax
NCT06515015 ·Status: RECRUITING ·Phase: NA
-
The ASTERS Study: Assessing the Role of Sphingolipids in AcuTE Respiratory Distress Syndrome (ARDS)
NCT03654352 ·Status: COMPLETED
-
A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)
NCT04662151 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury
NCT00036062 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old
NCT00578734 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled Nitric Oxide for ARDS-related Pulmonary Hypertension
NCT06249633 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Randomized Trial Comparing a Ventilatory Strategy To Prevent Atelectasis Versus a Lateral Decubitus Strategy During Robotic Bronchoscopy (VESPA vs. LADS Trial)
NCT05714033 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hazardous Surgical Smoke: Risk Assessment and Evaluation of a New Smoke Extractor System in the Surgical Unit
NCT03924206 ·Status: COMPLETED
-
Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome
NCT00295269 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS
NCT07449572 ·Status: RECRUITING ·Phase: PHASE1
-
Surgical Compared to Bronchoscopic Lung Volume Reduction in Patients With Severe Emphysema
NCT04537182 ·Status: RECRUITING ·Phase: NA
-
Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection
NCT04357730 ·Status: COMPLETED ·Phase: PHASE2
-
IBV Valve System for the Treatment of Prolonged Air Leak Under HDE H060002 - Post Approval Study
NCT01166516 ·Status: COMPLETED ·Phase: NA
-
Treprostinil Sodium Inhalation for Patients At High Risk for ARDS
NCT02370095 ·Status: TERMINATED ·Phase: PHASE2
-
Incidence of Acute Lung Injury: The Alien Study
NCT00736892 ·Status: COMPLETED
-
Inhaled Sevoflurane for ARDS Prevention
NCT05849779 ·Status: RECRUITING ·Phase: PHASE3
-
Safety Study of Inhaled Saline in Acute Lung Injury
NCT01713595 ·Status: WITHDRAWN ·Phase: PHASE1